The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease.
Head, Stuart J; Kaul, Sanjay; Mack, Michael J; Serruys, Patrick W; Taggart, David P; Holmes, David R; Leon, Martin B; Marco, Jean; Bogers, Ad J J C; Kappetein, A Pieter.
Eur Heart J
; 34(32): 2510-8, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23425523
How Do Hospitals Respond to Market Entry? Evidence from a Deregulated Market for Cardiac Revascularization.
Impact of Myocardial Revascularization Method on Smoking Cessation: Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention.
Koroner revaskülarizasyon (Dünya ve Türkiye örnekleri).
Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease.
Angioplastie ou chirurgie chez le patient coronarien stable ?
Implementation and consistency of Heart Team decision-making in complex coronary revascularisation.
Architecture of the Japan Ischemic Heart Disease Multimodal Prospective Data Acquisition for Precision Treatment (J-IMPACT) System.
Coronary artery revascularisation: selecting the appropriate strategy.
Hospital Phenotypes in the Management of Patients Admitted for Acute Myocardial Infarction.
Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries.